Items tagged with Advocacy
Community capacity building modules to accelerate DR-TB response (post with simple image)
Community capacity building modules to accelerate the response to drug-resistant TB launched at WHO meeting of national TB program managers and partners in the South-East Asia region.
Declaration of the Rights of People Affected by TB launched (post with simple image)
The launch of the Declaration is a significant step in recognizing the urgent need to adopt a human rights-based approach to TB and fund human rights-based interventions that overcome barriers to universal access.
Crisis of confidence in the WHO's ability to produce normative guidance for the treatment of RR-/MDR-TB (post with simple image)
Advocates request an urgent in-person meeting with the WHO leadership to discuss concrete actions to address technical and guideline development process-related issues previously raised.
FDA Antimicrobial Drugs Advisory Committee recommends approval of pretomanid (post with simple image)
Investigational drug pretomanid is under regulatory review by FDA for treatment of XDR-TB and treatment-intolerant or non-responsive MDR-TB as part of a new investigational regimen.
Advocates call on TB Alliance to make public the pretomanid licensing agreement with Mylan (post with simple image)
Advocates request full access to the terms of the agreement granting Mylan the rights to commercialize pretomanid.
Page 75 of 75 · Total posts: 0←First 74 75